​​​
  1. India’s Laurus Labs jumps over 16 per cent on market debut

India’s Laurus Labs jumps over 16 per cent on market debut

Indian generic drugmaker Laurus Labs Ltd's shares rose as much as 16.36 percent on their market debut on Monday after the company's initial public offering raised $196.6 million.

By: | Bengaluru | Published: December 19, 2016 12:11 PM
Drug maker, Laurus Labs Ltd, Visakhapatnam, API,  HIV/AIDS, National Stock Exchange Indian generic drug maker Laurus Labs Ltd’s shares rose as much as 16.36 percent on their market debut on Monday. (Reuters)

Indian generic drug maker Laurus Labs Ltd’s shares rose as much as 16.36 percent on their market debut on Monday after the company’s initial public offering raised $196.6 million.

The stock opened at 489.90 rupees on the National Stock Exchange and rose to a high of 498 rupees, compared with the IPO issue price of 428 rupees.
Based in Visakhapatnam, Laurus makes active pharmaceutical ingredients (API), or drug raw materials, that go into the making a range of medicines, chiefly HIV/AIDS drugs.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Go to Top